Literature DB >> 14903504

Antituberculous properties of hydrazines of isonicotinic acid (rimifon, marsilid).

W STEENKEN, E WOLINSKY.   

Abstract

Entities:  

Keywords:  NICOTINIC ACID/derivatives; TUBERCULOSIS/experimental

Mesh：

Substances：

Year:  1952        PMID： 14903504     DOI： 10.1164/art.1952.65.4.365

Source DB:  PubMed          Journal:  Am Rev Tuberc        ISSN： 0096-0381


× No keyword cloud information.
  5 in total

1.  Studies in experimental ocular tuberculosis. XVII. The effect of isoniazid in the normal, nonimmune rabbit.

Authors:  A C WOODS; B BECKER; R M WOOD
Journal:  Trans Am Ophthalmol Soc       Date:  1953

2.  Isoniazid in childhood tuberculosis.

Authors:  G BOYD; T E ROY; A JOSIUKAS
Journal:  Can Med Assoc J       Date:  1953-09       Impact factor: 8.262

3.  Bacterial resistance to isoniazid and marsilid in treatment of pulmonary tuberculosis; results of trials.

Authors:  C M OGILVIE
Journal:  Br Med J       Date:  1954-10-09

4.  A simple blood medium for determining the susceptibility of Mycobacterium tuberculosis to isoniazid (isonicotinic acid hydrazide).

Authors:  M S TARSHIS
Journal:  J Bacteriol       Date:  1954-01       Impact factor: 3.490

5.  Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis.

Authors:  K Takayama; L Wang; H L David
Journal:  Antimicrob Agents Chemother       Date:  1972-07       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.